Lv12
20 积分 2024-07-30 加入
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
5小时前
已完结
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer
21小时前
已完结
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
21小时前
已完结
Single Agent VS-6766 or VS-6766 Plus Defactinib in KRAS -Mutant Non-Small-Cell Lung Cancer: The RAMP-202 Phase II Trial
21小时前
已完结
PR029/#943 A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of therapy in patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-ov81/NCRI/RAMP 301
3天前
求助中
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
14天前
已完结
Immune cell membrane-coated nanoparticles for targeted myocardial ischemia/reperfusion injury therapy
28天前
已完结
Differential expression of Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in mucosa and mesenteric fat tissue of Crohnʼs disease patients
1个月前
已完结
Cryo-EM structure of human sphingomyelin synthase and its mechanistic implications for sphingomyelin synthesis
1个月前
已完结
Gastrodenol suppresses NLRP3/GSDMD mediated pyroptosis and ameliorates inflammatory diseases
1个月前
已完结
皖公网安备34019202002308
